Priority-setting decisions for new cancer drugs [5] (multiple letters)

Alasdair Millar; Douglas K. Martin; Joseph L. Pater; Peter A. Singer; Keith Wheatley; Benjamin Djulbegovic; Axel Glasmacher

Priority-setting decisions for new cancer drugs [5] (multiple letters)

Alasdair Millar^*, Douglas K. Martin, Joseph L. Pater, Peter A. Singer, Keith Wheatley, Benjamin Djulbegovic, Axel Glasmacher

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1524-1525
Number of pages	2
Journal	Lancet
Volume	359
Issue number	9316
Publication status	Published - 27 Apr 2002

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{b942260459114d648512f3e718bc683d,

title = "Priority-setting decisions for new cancer drugs [5] (multiple letters)",

author = "Alasdair Millar and Martin, {Douglas K.} and Pater, {Joseph L.} and Singer, {Peter A.} and Keith Wheatley and Benjamin Djulbegovic and Axel Glasmacher",

year = "2002",

month = apr,

day = "27",

language = "English",

volume = "359",

pages = "1524--1525",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "9316",

}

TY - JOUR

T1 - Priority-setting decisions for new cancer drugs [5] (multiple letters)

AU - Millar, Alasdair

AU - Martin, Douglas K.

AU - Pater, Joseph L.

AU - Singer, Peter A.

AU - Wheatley, Keith

AU - Djulbegovic, Benjamin

AU - Glasmacher, Axel

PY - 2002/4/27

Y1 - 2002/4/27

UR - http://www.scopus.com/inward/record.url?scp=0037181721&partnerID=8YFLogxK

M3 - Letter

C2 - 11988280

AN - SCOPUS:0037181721

SN - 0140-6736

VL - 359

SP - 1524

EP - 1525

JO - Lancet

JF - Lancet

IS - 9316

ER -